Expedeon develops cutting-edge technological tools for use in biological research, diagnostics and drug discovery. The Cambridge-based company has offices, laboratories and manufacturing facilities in the UK, the US, Spain, Australia and Singapore.
BOOST&Co provided Expedeon with a growth capital loan of £5m in March 2018, to fund the acquisition of a reagents business based in Australia.
Member count: 51-200
Total raised: $392.752K
Founded date: 2003
Investors 2
| Date | Name | Website |
| 17.07.2021 | BOOST&... | boostandco... |
| - | Cambridge ... | cambridgec... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.09.2014 | - | $392.752K | - | cambridgen... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 06.08.2019 | Expedeon A... | Expedeon AG signs commercial a... | - | - | cambridgen... |
| 27.02.2019 | Cofinitive... | Cofinitive shortlisted for Int... | - | - | cambridgen... |
| 22.09.2014 | Cambridges... | Cambridgeshire’s Expedeon expa... | - | - | cambridgen... |
| 22.09.2014 | Cambridges... | Cambridgeshire-based Expedeon,... | - | - | cambridgen... |